ERIC PAUL BENNETT

A new paper from @WilsonLab2 @TimmKoller @MartinoMorici reports structures of the O-glycosylated antimicrobial peptide Drosocin in complex with the bacterial ribosome, revealing how Drosocin inhibits the termination phase of protein synthesis. Open access: nature.com/articles/s4158…

@pdhsu We are digging into this, chemestries are quite different, so assays not directly transferable, but so far they generate comparable data.

@ERICPBENNETT How does this compare to Biorad?

What is your favorite ddPCR system? Is there a better (cheaper) version than the Bio-Rad machine, or a way to home-brew the reagents?

@pdhsu Precise Integration of Inducible Transcriptional Elements (PRIITE) enables absolute control of gene expression. For more information check out R.Pinto et al., NAR, 2017!

What is your favorite, non-leaky, drug inducible system? Dox-based systems have been very problematic for us

@BagdonaiteIeva @cphglyco @WandallLab @jcpJim Very interesting study!

Our take on O-glycosylation of SARS-CoV-2 spike - a lot of our mapped O-glycosites reside close to known N-glycosites! In those cases, O-glycans are most often seen on peptides unoccupied by N-glycans. biorxiv.org/cgi/content/sh… #bioRxiv #glycopreprint @cphglyco @WandallLab @jcpJim

Congrats with the move Patrick! Exiting times, I'm sure you'll do great!

After overwhelming interest and thanks to great talks by: Samantha Maragh, Roberto Nitsch, Marcello Maresca, Jason Potter, Casey Jowdy, Kevin Holden, and others, this years 6th annual Precision CRISPR mini-symposium, became a great success. Heads up for our next event, next year!

Thanks to all students for a successful end of the 4th bi-annual 2 week Ph.D Course “Gene Targeting and Editing”. Students gained hands-on experience with anti-sense, CRISPR/Cas9 in bacteria, CRISPR/Cas9, ZFN and TALEN in mammalian cells and learn how to perform T7EI and IDAA.

The full program for the forthcoming “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing”, mini-symposium is now available. Interest has been overwhelming and we look forward to an exciting event with presentations from…lnkd.in/dDipMEH

Pleased to welcome You All to our yearly CRISPR mini-symposium entitled: “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing”, Mini-symposium, August 30th, 2019! ida.dk/arrangement/pr…

Great opportunity for pre- and post –graduate students to catch up on the basics and translational aspects of CRISPR/Cas9 gene editing! coetus.dk/2019/04/22/08-…

@jcornlab @BeekeWienert @staciakwyman @richardson_lab Congrats to a great scientific contribution!

Want to watch #CRISPR doing its thing in patient iPSCs and mice? Give DISCOVER-seq a try. Congrats to @BeekeWienert @staciakwyman @richardson_lab, and thanks to our wonderful collaborators! Follow up tweets have detailed protocols and software. science.sciencemag.org/content/364/64…

@jcornlab @BeekeWienert @staciakwyman @richardson_lab Congrats to a great scientific contribution

Cobo Technologies has been enrolled in the US NIST Genome Editing Consortium. A great opportunity for Cobo Technologies to contribute and interact on establishing guidelines and “best practice” procedures for measuring genome editing outcomes. cobotechnologies.com/newsitem/cobo-…

Instant identification and quantification of ex vivo CRISPR/Cas9 editing outcomes in primary cells! Our detailed protocol can be found in the "CRISPR Gene Editing methods and Protocols" collection that is finally out. link.springer.com/protocol/10.10…

Looking forward to present and network at the Therapeutic Genome Editing Congress, March 20th-21st  in Boston, with presence of leading institutions in the genome editing field. therapeuticgenomeediting.com/events/therape…

Hello Twitter! #myfirstTweet